I don't usually like dilution too much, but having Mark Creasy take a 16% holding in MYL is fantastic news. CR won't be too far away, but it will be an excellent opportunity to get more, lets see.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025